The Aethel Science Consortium — Riverrun Division — did not look like a hospital.
It looked like a conclusion.
Glass and white composite curved upward in calculated arcs, each surface engineered to diffuse rather than reflect light. At the entrance, a volumetric projector suspended the building's name midair in clean photonic script. Clover read it once, then looked away. He already knew what it said.
Behind him, Sav's glide car idled at the curb, hovering a half-metre above the road.
"You going in," Theo called from the passenger window, "or are you just going to admire it?"
Clover adjusted his cuff. Black suit. Nothing excessive.
"I'm going in."
"Bale name does half the work anyway," Theo said. No malice. Just fact.
Clover didn't answer. He turned and walked up the steps, and the door read his biometric signature before he touched it.
· · ·
Inside, everyone moved with intent. Not hurried — efficient. The particular quality of minds operating above baseline threshold. Holographic displays floated at eye level running neural thermal maps, synaptic firing indexes, post-Breakthrough metabolic panels.
The reception unit activated before he reached the desk.
"Identity confirmed. Clover Bale. Interview with Dr. Marcus Hale. Interview Room Three, Level Two, Corridor Delta."
"I didn't scan anything."
"Passive biometric acquisition upon entry," it replied. "Thermal signature, gait recognition, and retinal geometry. No action required from you."
A light strip activated along the floor. Clover followed it.
As he walked, data bled through the semi-transparent corridor walls. He caught one line before it scrolled past:
Phase One Overdrive Threshold — 18.7% Efficiency Index | Neural Haemorrhage Probability Above Threshold: +63%
He kept walking.
· · ·
Interview Room Three. One chair, one table, one inactive wall display.
The door opened. Dr. Aryn Bale walked in and crossed the room and hugged him before he could stand properly. No formality.
"You made it," she said.
"I was always going to make it."
She pulled back and read his face.
"You're nervous."
"I'm not."
"You are."
"Fine. A little."
She smiled and held it briefly.
"A Breakthrough is not the greatest thing a person can achieve," she said. "I have watched forty-six people die in Phase One in this building. If I could choose, I would have you beside me every time — because when you break through, I want to be the one holding the serum."
Clover laughed — sharp, unexpected.
"That is either comforting or alarming."
"Both," she said, already at the door. "Handle the interview. I'll find you after."
She left.
Three seconds later it opened again.
· · ·
Dr. Marcus Hale sat down across from Clover without greeting him. He did not activate the interface. The wall display stayed dark. No camera. No recording.
"You're not starting the system."
"No. We don't need it."
Hale folded his hands.
"You are Clover Bale. Son of Dr. Aryn Bale — author of the serum-delivery protocol now standard across thirty-seven facilities in Aethelgard. Son of Dr. Christian Bale — a surgeon operating at precision levels most Phase Two individuals cannot replicate in their own fields. The Bale family has produced consistent high-level medical performance across three generations. Your mother entered the lineage as a prodigy herself."
He paused.
"And you have not had a Breakthrough."
Not a question. A placement.
"No," Clover said.
Something shifted behind Hale's expression. Not dramatic. Micro-compression around the eyes. The natural signal of a man whose assessment had been confirmed in the wrong direction.
"You are becoming a disappointment to your parents and your family legacy," Hale said. No cruelty. No cushioning. "I hope that changes soon."
He stood.
"This interview is unnecessary. You will be accepted to this institution regardless of your performance in this room."
"That doesn't make sense."
"Your mother's protocol has prevented an estimated nineteen deaths in this facility over four years. I am not going to deny her son an internship over formality."
"So I'm here because of her name."
"You are here because of your name," Hale corrected. "Which carries hers."
He paused at the door.
"Expectation is not pressure, Clover. Pressure dissipates. Expectation accumulates. It does not care whether you acknowledge it or not."
He left.
Clover sat in the empty room.
Not shocked.
In recognition.
Which was worse.
· · ·
Aryn found him in the corridor and read his face again and chose not to ask.
"Come. I'll show you around."
Three sections. Three minutes each.
First — the stabilisation ward. Glass-partitioned rooms. Phase One patients in controlled states, some sedated, some wide-eyed and tracking things that weren't there. Neural stabiliser cuffs at wrists and temples. Wall displays showed brain temperature, ATP depletion curves, cerebrovascular pressure in real time.
One patient — male, early twenties — sat completely still with his eyes moving at a speed that had no natural correspondence to anything in the room.
"Visual cortex processing at roughly 340% of standard baseline input," Aryn said. "The world appears almost frozen to him. He's been like this for nineteen hours."
Second — the laboratory. Post-Breakthrough blood composition on layered displays. Elevated mitochondrial density. Remodelled glucose transport channels. Altered metabolic signatures that the body built automatically once the brain crossed the threshold.
Clover slowed at one graph.
"Energy demand doubles between 10 and 25%," Aryn said. "Triples between 25 and 45. The body compensates. But the system has limits."
Third — manufacturing. Two storeys of automated serum production. Robotic dispensing units measuring each dose to microgram precision in sealed, sterile chambers.
"Too little, the brain's output boost is insufficient to stabilise," she said. "Too much—"
"It kills them," Clover finished.
"The therapeutic window is eleven micrograms per adjusted kilogram of body mass."
Eleven micrograms.
He didn't say anything.
· · ·
The intern workspace was at the far end of Level Two. Three people. Already watching him before he reached the door.
Aryn left him at the threshold.
"I'm Clover."
The taller boy didn't move.
"We know. Ethan Cole. 22%."
"Luca Ferris. 23%."
The girl stayed leaning against the desk.
"Mira Seld. 25%."
A pause.
Then Ethan:
"Wait — you're actually still baseline? You're a Bale and you haven't broken through yet?"
"Yes."
"Impressive," Luca said. "Not in a good way."
Clover kept his expression flat.
"Does it matter?"
"For the work we do here? Yes," Ethan said. "We process differently. Our brains handle data at a rate you physically can't match right now."
"What's the difference between 22 and 23%?"
Luca's expression tightened.
"There is a difference."
"I know there is. I asked how much."
Mira cut in before Luca answered.
"You can't accurately calculate differences between levels you haven't reached. You cannot model a physiological state from the outside." Her voice was level. No raised edge. Just exact. "That's not an insult. That's a structural problem."
Clover looked at her.
He had no response.
Because she was right.
And that was the most frustrating kind of opposition.
· · ·
He sat on a bench near reception and let the atrium move around him.
Hale's voice. Ethan's expression. Mira's three precise sentences.
"Why am I like this?"
He already knew.
"I'm a Bale."
That was the load-bearing answer. Three generations of performance. A mother who had rewritten Phase One survival rates. A father operating on the organ that kept people in the world. And him — seventeen, baseline, not yet, still waiting.
Footsteps.
Mira sat beside him. Not too close.
"Rough start," she said.
"Was it obvious?"
"Somewhat."
She looked ahead.
"My father never had a Breakthrough. Baseline his entire life. He died peacefully — the only person I've ever watched die that way. People like us, our brains don't stop. The metabolic demand is constant. We regulate, we restrict, we schedule rest like engineers schedule maintenance. A person at 25% who overworks isn't stronger — they're a more precisely built machine running past its operational tolerance."
She turned toward him.
"You're not broken. You're just not what they expected. There's a difference."
"Thank you," he said. "You didn't have to say that."
"I know."
He leaned back.
"I will have a Breakthrough."
"Most people do."
"No — when I do, it's going to be something larger than expected. I don't have a logical basis for that. I'm just telling you."
She looked at him for a moment.
"How much larger?"
He glanced sideways.
"Maybe I'll be the first to jump straight to fifty percent in a single transition."
Mira stared at him.
Then laughed — real, unguarded, briefly unscientific.
"And maybe I'll rewrite the metabolic energy model before lunch."
"Maybe," Clover said.
They sat in the quiet of the atrium.
The Consortium ran around them — thermal scanners cycling, data streams updating, the manufacturing floor eleven micrograms from disaster on every single dose.
And for the first time that day, Clover Bale didn't look like someone trying to prove something.
He looked like someone who had already decided something,
and was simply waiting for the world to catch up.
— END OF CHAPTER 2 —